塩野義製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/01/12 | 7,373 | 7,373 | 7,256 | 7,309 | +53 | +0.7% | 1,617,600 |
| 2024/01/11 | 7,195 | 7,259 | 7,193 | 7,256 | +121 | +1.7% | 1,277,600 |
| 2024/01/10 | 7,061 | 7,150 | 7,042 | 7,135 | +126 | +1.8% | 1,215,800 |
| 2024/01/09 | 6,983 | 7,068 | 6,958 | 7,009 | +126 | +1.8% | 1,323,600 |
| 2024/01/05 | 7,004 | 7,014 | 6,883 | 6,883 | -45 | -0.6% | 943,200 |
| 2024/01/04 | 6,808 | 6,930 | 6,741 | 6,928 | +130 | +1.9% | 1,329,800 |
| 2023/12/29 | 6,775 | 6,813 | 6,756 | 6,798 | +11 | +0.2% | 683,100 |
| 2023/12/28 | 6,796 | 6,839 | 6,785 | 6,787 | -36 | -0.5% | 429,500 |
| 2023/12/27 | 6,808 | 6,857 | 6,796 | 6,823 | +41 | +0.6% | 699,000 |
| 2023/12/26 | 6,792 | 6,828 | 6,765 | 6,782 | -10 | -0.1% | 376,400 |
| 2023/12/25 | 6,854 | 6,854 | 6,783 | 6,792 | +2 | ±0% | 391,200 |
| 2023/12/22 | 6,766 | 6,811 | 6,753 | 6,790 | +24 | +0.4% | 739,800 |
| 2023/12/21 | 6,914 | 6,914 | 6,764 | 6,766 | -189 | -2.7% | 1,026,400 |
| 2023/12/20 | 7,029 | 7,090 | 6,955 | 6,955 | -24 | -0.3% | 1,138,300 |
| 2023/12/19 | 7,000 | 7,040 | 6,921 | 6,979 | +27 | +0.4% | 995,000 |
| 2023/12/18 | 6,900 | 6,975 | 6,860 | 6,952 | -70 | -1% | 1,046,000 |
| 2023/12/15 | 7,167 | 7,169 | 6,987 | 7,022 | -88 | -1.2% | 1,723,700 |
| 2023/12/14 | 7,111 | 7,135 | 7,058 | 7,110 | +47 | +0.7% | 1,142,800 |
| 2023/12/13 | 7,280 | 7,289 | 7,062 | 7,063 | -179 | -2.5% | 895,100 |
| 2023/12/12 | 7,189 | 7,274 | 7,189 | 7,242 | +105 | +1.5% | 1,295,800 |
| 2023/12/11 | 7,140 | 7,231 | 7,120 | 7,137 | +109 | +1.6% | 1,406,100 |
| 2023/12/08 | 7,046 | 7,058 | 6,966 | 7,028 | -36 | -0.5% | 1,606,200 |
| 2023/12/07 | 7,089 | 7,126 | 7,051 | 7,064 | -16 | -0.2% | 1,117,600 |
| 2023/12/06 | 6,988 | 7,086 | 6,974 | 7,080 | +119 | +1.7% | 824,100 |
| 2023/12/05 | 6,974 | 6,993 | 6,912 | 6,961 | ±0 | ±0% | 841,700 |
| 2023/12/04 | 6,964 | 6,979 | 6,910 | 6,961 | -79 | -1.1% | 603,800 |
| 2023/12/01 | 7,030 | 7,062 | 7,015 | 7,040 | +62 | +0.9% | 837,900 |
| 2023/11/30 | 6,884 | 6,986 | 6,846 | 6,978 | +108 | +1.6% | 2,703,800 |
| 2023/11/29 | 6,888 | 6,909 | 6,814 | 6,870 | -85 | -1.2% | 863,000 |
| 2023/11/28 | 6,961 | 6,982 | 6,928 | 6,955 | -15 | -0.2% | 774,500 |
| 2023/11/27 | 7,053 | 7,096 | 6,970 | 6,970 | -80 | -1.1% | 691,200 |
| 2023/11/24 | 7,035 | 7,106 | 7,033 | 7,050 | +82 | +1.2% | 899,100 |
| 2023/11/22 | 6,945 | 7,027 | 6,934 | 6,968 | -7 | -0.1% | 819,000 |
| 2023/11/21 | 7,085 | 7,085 | 6,925 | 6,975 | -122 | -1.7% | 1,176,500 |
| 2023/11/20 | 7,121 | 7,171 | 7,092 | 7,097 | -5 | -0.1% | 979,800 |
| 2023/11/17 | 7,079 | 7,122 | 7,061 | 7,102 | +32 | +0.5% | 981,700 |
| 2023/11/16 | 7,045 | 7,091 | 7,041 | 7,070 | -2 | ±0% | 893,000 |
| 2023/11/15 | 7,065 | 7,122 | 7,011 | 7,072 | +16 | +0.2% | 1,226,400 |
| 2023/11/14 | 7,090 | 7,105 | 7,003 | 7,056 | -26 | -0.4% | 867,400 |
| 2023/11/13 | 7,140 | 7,182 | 7,073 | 7,082 | +1 | ±0% | 1,224,500 |
| 2023/11/10 | 7,077 | 7,092 | 7,043 | 7,081 | +2 | ±0% | 898,300 |
| 2023/11/09 | 7,065 | 7,081 | 7,016 | 7,079 | +14 | +0.2% | 860,400 |
| 2023/11/08 | 7,100 | 7,109 | 7,042 | 7,065 | -5 | -0.1% | 1,176,300 |
| 2023/11/07 | 7,122 | 7,181 | 7,065 | 7,070 | -52 | -0.7% | 1,166,300 |
| 2023/11/06 | 7,179 | 7,189 | 7,074 | 7,122 | +19 | +0.3% | 1,328,700 |
| 2023/11/02 | 7,154 | 7,179 | 7,070 | 7,103 | -49 | -0.7% | 1,371,100 |
| 2023/11/01 | 7,050 | 7,154 | 6,966 | 7,152 | +165 | +2.4% | 2,149,500 |
| 2023/10/31 | 6,907 | 7,064 | 6,865 | 6,987 | +126 | +1.8% | 2,040,900 |
| 2023/10/30 | 6,857 | 6,909 | 6,842 | 6,861 | -69 | -1% | 1,440,900 |
| 2023/10/27 | 6,804 | 6,930 | 6,784 | 6,930 | +93 | +1.4% | 1,060,700 |
301～
350
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 塩野義 | 233,400円 | +5.7% | +3.9% | 2.46% | 11.61倍 | 1.54倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| 大塚ＨＤ | 760,400円 | +2.2% | +10.2% | 1.58% | 14.64倍 | 1.47倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 139,000円 | +18.5% | -96.0% | 5.32% | 177.75倍 | 1.63倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 協和キリン | 220,400円 | -3.5% | -11.3% | 2.72% | 20.24倍 | 1.36倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| エーザイ | 394,200円 | +1.7% | -2.9% | 4.06% | 25.86倍 | 1.36倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム
